Integration of Serum Protein Biomarker and Tumor Associated Autoantibody Expression Data Increases the Ability of a Blood-Based Proteomic Assay to Identify Breast Cancer

This research article was published in PLOS ONE 2016 and discusses how the discovery of key biomarkers and protein signatures for breast cancer and proteomic technologies are currently poised to serve as an ideal diagnostic adjunct to imaging. 

Learn more by downloading the publication from PLOS ONE

HUPO-2016densebreast.png

Download Publication